Product Description
Mechanisms of Action:
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Belgium | Chile | Dominican Republic | France | Italy | Korea | Luxembourg | Mexico | Peru | Portugal | Romania
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
08/08/2022 |
PubMed |
Ethyl loflazepate as a treatment for patients with idiopathic and psychogenic taste disorder. |
|
07/19/2022 |
PubMed |
Trends and Geographic Variabilities in Benzodiazepines Prescription in Primary Care to Older Adults: A 3-Year Population-Based Ecological Study in Portugal. |
|
01/01/2006 |
PubMed |
Ethyl Loflazepate. |